France restricts AstraZeneca vaccine to under-65s

February 2, 2021 By La rédaction de Mediapart

The French health regulator said there was still not enough data about the effectiveness of the AstraZeneca vaccine for patients over 65 years of age.

Reading articles is for subscribers only. Subscribe now.

The French health authority has said AstraZeneca's Covid-19 vaccine should only be given to people aged under 65, reports the BBC.

Your choice for your data

To make the Mediapart website and mobile application available to you we use cookies or similar technologies that allow us to collect information about your device.

Some of these technologies are necessary to make our services work properly: you cannot refuse them. Others are optional but help facilitate your experience as a reader and in some way support Mediapart : you can give or withdraw your consent at any time.

Do you agree that Mediapart may use cookies or similar technologies useful to its operation ?

Refine my choices

The cookies and similar technologies we use on Mediapart are of different natures and allow us to pursue different purposes.

Some are necessary for the functioning of the site and the mobile application (you cannot refuse them). Others are optional but help to facilitate your experience as a reader and in some way support Mediapart. You can refuse or accept them below, depending on their purpose.

Do you agree that Mediapart uses cookies or similar technologies for the following purposes ?

You can make your choice, for each category, by enabling or disabling the switch button.

Mandatory for the operation
of the site or application

Subscriber login, anonymized audience measurement, sending of push notifications, tracking of failures, highlighting of our services these tools are necessary to track the activity of our services and their proper functioning.

France restricts AstraZeneca vaccine to under-65s

You are a subscriberLogin

If you are not already a subscriber,subscribe here

You are a subscriber
Login

If you are not already a subscriber,
subscribe here